Home Tags Antibiotic Resistance
Antibiotic Resistance Related Content
Neil Osheroff from the Vanderbilt University School of Medicine is working to overcome drug resistance and revitalise the use of established targets for antibacterial agents, as we discover here.
Daniel Berman, Head of Global Health, Nesta Challenges, says that it should not have taken COVID-19 to emphasise the necessity of rapid testing.
Writer Megan Warrender looks at strengthening research and innovation in strategically important areas such as automation, antibiotic resistance and quantum technology.
Nina Lindfors, Director of Teaching and Research at Helsinki University Hospital, illuminates us about a new approach to infection treatment that concerns an antibacterial bioactive glass for bone reconstruction.
Peter Jackson, Executive Director of the AMR Centre, describes new initiatives and partnerships that point the way forward for the UK’s antimicrobial resistance response.
Daniel Berman, Head of Global Health, Nesta Challenges, highlights the need for radical change in how innovation is funded and prioritised to ensure an antibiotic future given AMR is still climbing, even though behaviours are changing.
Here, we focus on some of the key issues facing the pharmaceutical industry throughout Europe.
Only 11% of Brits see antimicrobial resistance as a serious threat to society, despite the outgoing UK Chief Medical Officer saying earlier this year that Superbugs “could kill us before climate change does”.
The Keep Antibiotics Working campaign is back to alert the public to the risks of antibiotic resistance, urging people to always take their doctor, pharmacist or nurse’s advice.
Resistance to antibiotics used for treating harmful bacteria related to a variety of stomach conditions has more than doubled in 20 years, new research presented at UEG Week Barcelona 2019 has shown.
Paula Gomes, Associate Professor of Chemistry and Senior Researcher in Bioorganic and Peptide Chemistry at the University of Porto, Portugal, explains why peptides are amongst the most promising molecules for the future.
The EU-funded project FLEXPOL (GA number 721062) offers an affordable approach to prohibit the spread of bacteria and healthcare-associated infections using cost-effective and sustainable film products.
The priorities of Vytenis Andriukaitis, the current European Commissioner for Health & Food Safety are explained here.
The NHS will test the world's first ‘subscription’ style payment model to incentivise pharmaceutical companies to develop new drugs for resistant infections.
Concentrations of antibiotic contamination found in some of the world’s rivers exceed ‘safe’ levels by up to 300 times, according to researchers at the University of York.
The United Nations (UN) Food and Agriculture Organization (FAO) has awarded official designation to the UK International Reference Centre for antimicrobial resistance (AMR).
Applying the economics of climate change to antimicrobial resistance could help to avert the 10 million deaths that are predicted to occur by 2050 if urgent action isn’t taken.
While Africa has made progress in tackling tuberculosis (TB), it still has one of the highest TB rates in the world and remains a priority.
Government has published 5-year national action plan and a 20-year vision for how the UK will contribute to containing and controlling antimicrobial resistance.
Research indicates that Antimicrobial Resistance is an issue which claims thousands of lives each year, 10 million by 2050.